Sociedad Americana de Hirudoterapia

Global spread and antimicrobial resistance of Aeromonas hydrophila in aquatic food animals: a systematic review and meta-analysis

Research article published in Scientific reports (2025)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Meta-analysisResistencia antimicrobianaJeamsripong S et al. · Scientific reports, 2025

Abstract

Aeromonas hydrophila is a common zoonotic agent in aquatic environments that causes gastroenteritis and wound infections in both humans and animals through foodborne and hospital-acquired infection. Antimicrobial resistance (AMR) combination with virulence factors enhances treatment challenging. The prevalence and AMR of Aeromonas hydrophila have been increasingly reported, posing a significant threat to both animal and public health. This systematic review and meta-analysis aimed to determine the prevalence of A. hydrophila and its resistance to aquatic food animals. A comprehensive search for relevant studies was conducted on Google Scholar, PubMed, ScienceDirect, and Scopus, following the PRISMA guidelines, covering studies from January 2020 to December 2024. The quality of the included publications was evaluated using the Joanna Briggs Institute critical appraisal tool. Differences in the prevalence and AMR of A. hydrophila were assessed using a random-effect model. A total of 14,077 studies were screened, and 14 publications were included. Bacterial isolation of A. hydrophila was achieved using various standard protocols, involving culture on Rimler-Shotts (RS) agar and Tryptic Soy Agar (TSA), with or without antimicrobials. Subsequent biochemical identification confirmed the isolates. The pool prevalence of A. hydrophila (30.7%, 95% C.I.:17.0-46.3%), and the distribution of virulence genes were 71.2%. The most common resistance observed to penicillin (80.7%), oxytetracycline (69.9%) and macrolides (67.8%). The most prevalent AMR genes identified were blaTEM (67.0%), followed by tetA (63.7%). The increasing presence of A. hydrophila in aquaculture suggests a considerable risk of disease. The prevalence of both A. hydrophila and AMR was higher in Africa than in Asia, indicating regional variations in the AMR pattern. However, monitoring and surveillance of A. hydrophila remained limited. A major limitation of this study was the heterogeneity in effect estimates across the selected studies. Nonetheless, the quality assessment conducted indicated that this variability did not compromise the consistency or reliability of the findings.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleSystematic ReviewMeta-Analysis
Indexed MeSH termsAeromonas hydrophilaAnimalsGram-Negative Bacterial InfectionsAnti-Bacterial AgentsDrug Resistance, BacterialHumans

Resumen

Peer-reviewed research on antimicrobial resistance relevant to medicinal leech therapy and associated bacterial flora. Indexed in PubMed and verified against the NCBI record.

Por qué esto importa para la hirudoterapia

Esta revisión sistemática y metaanálisis (14 estudios agrupados, siguiendo PRISMA) estimó la prevalencia de *Aeromonas hydrophila* en animales acuáticos de consumo en un 30,7% y encontró alta resistencia a penicilina (80,7%), oxitetraciclina (69,9%) y macrólidos (67,8%), con *blaTEM* y *tetA* los genes de resistencia más comunes. Esto es directamente relevante para la hirudoterapia porque *A. hydrophila* es el simbionte intestinal principal de la lombriz medicinal y la causa principal de infección de herida tras terapia con lombriz, por lo que la resistencia antimicrobiana creciente y amplia en *Aeromonas* ambiental tiene impacto en la elección y fiabilidad de la profilaxis antibiótica que acompaña la aplicación clínica de lombrices. Nota: esta es una revisión de aislamientos veterinarios/acuícolas, no de infecciones clínicas derivadas de lombrices, y los autores señalan una heterogeneidad sustancial entre los estudios, por lo que informa sobre el panorama de resistencia en lugar de dictar cualquier régimen de profilaxis específico.

Citación

Global spread and antimicrobial resistance of Aeromonas hydrophila in aquatic food animals: a systematic review and meta-analysis.

Jeamsripong S et al. · Scientific reports, 2025

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.